These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 30620480)

  • 1. [How Far is "Personalized Medicine" for Depression from Clinical Use?].
    Kato M
    Seishin Shinkeigaku Zasshi; 2016; 118(8):615-624. PubMed ID: 30620480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics and personalized medicine in antidepressant treatment.
    Gvozdic K; Brandl EJ; Taylor DL; Müller DJ
    Curr Pharm Des; 2012; 18(36):5853-78. PubMed ID: 22681166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic testing and personalized treatment of depression.
    Perlis RH
    Clin Chem; 2014 Jan; 60(1):53-9. PubMed ID: 24281779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying genetic loci affecting antidepressant drug response in depression using drug-gene interaction models.
    Noordam R; Avery CL; Visser LE; Stricker BH
    Pharmacogenomics; 2016 Jun; 17(9):1029-40. PubMed ID: 27248517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies.
    Fabbri C; Serretti A
    Neurosci Lett; 2020 May; 726():133651. PubMed ID: 29906483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic guidelines and decision support tools for depression treatment: application to late-life.
    Chang DD; Eyreeuro HA; Abbott R; Coudreaut M; Baune BT; Shaman JA; Lavretsky H; Lenze EJ; Merrill DA; Singh AB; Mulsant BH; Reynolds CF; Müller DJ; Bousman C
    Pharmacogenomics; 2018 Nov; 19(16):1269-1284. PubMed ID: 30422065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association studies of antidepressant outcome: a brief review.
    Laje G; McMahon FJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1553-7. PubMed ID: 21115088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of antidepressants, mood stabilizers, and antipsychotics in diverse human populations.
    Murphy E; McMahon FJ
    Discov Med; 2013 Sep; 16(87):113-22. PubMed ID: 23998447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
    Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
    BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prediction and Personalized Medicine of Antidepressant Treatment in Japanese MDD Patient].
    Kato M
    Seishin Shinkeigaku Zasshi; 2016; 118(3):139-146. PubMed ID: 30620509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic studies in depression: a proposal for methodologic guidelines.
    Serretti A; Kato M; Kennedy JL
    Pharmacogenomics J; 2008 Apr; 8(2):90-100. PubMed ID: 17684474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
    Leblé N; Radon L; Rabot M; Godart N
    Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of genotyping cytochrome P450 enzymes in the treatment of depression.
    Dubovsky SL
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):369-79. PubMed ID: 25554071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of asthma: toward precision medicine.
    Kersten ET; Koppelman GH
    Curr Opin Pulm Med; 2017 Jan; 23(1):12-20. PubMed ID: 27764000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.
    Lett TA; Walter H; Brandl EJ
    CNS Drugs; 2016 Dec; 30(12):1169-1189. PubMed ID: 27752945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The search for personalized antidepressant treatments: what have we learned and where are we going.
    Serretti A; Fabbri C
    Pharmacogenomics; 2020 Oct; 21(15):1095-1100. PubMed ID: 33016213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized medicine for depression: can we match patients with treatments?
    Simon GE; Perlis RH
    Am J Psychiatry; 2010 Dec; 167(12):1445-55. PubMed ID: 20843873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment].
    Kato M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):83-92. PubMed ID: 20491282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.
    Altar CA; Carhart JM; Allen JD; Hall-Flavin DK; Dechairo BM; Winner JG
    Pharmacogenomics J; 2015 Oct; 15(5):443-51. PubMed ID: 25686762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.
    Serretti A; Benedetti F; Zanardi R; Smeraldi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1074-84. PubMed ID: 15939518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.